Biokinetics of 18F-choline studied in four prostate cancer patients

Radiation Protection Dosimetry

Volumn 139, Issue 1-3, 2010, Pages 240-244

  Uusijarvi H ^a   Nilsson, L E ^a   Bjartell, A ^a   Mattsson, S ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUOROCHOLINE; RADIOPHARMACEUTICAL AGENT;

ANTIBODY SPECIFICITY; ARTICLE; HUMAN; KINETICS; MALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; PROSTATE TUMOR; RADIATION DOSE; RADIOMETRY; SCINTISCANNING; TISSUE DISTRIBUTION;

CHOLINE; HUMANS; KINETICS; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 77953305288     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncq024     Document Type: Article

References (19)

1. Hofer, C., Laubenbacher, C., Block, T., Breul, J., Hartung, R. and Schwaiger, M. Fluorine-18-fluoro-deoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur. Urol. 36, 31-35 (1999).
2. Liu, I. J., Zafar, M. B., Lai, Y. H., Segall, G. M. and Terris, M. K. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 57, 108-111 (2001).
3. Powles, T., Murray, I., Brock, C., Oliver, T. and Avril, N. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur. Urol. 51, 1511-1520; discussion 1520-1521 (2007).
4. 18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J. Urol. 168, 273-280 (2002).
5. Schoder, H. and Larson, S. M. Positron emission tomography for prostate, bladder, and renal cancer. Semin. Nucl. Med. 34, 274-292 (2004).
6. 11C-choline positron emission tomography. Eur. Urol. 42, 18-23 (2002).
7. 11C-choline and 2-deoxy-2-[18F]fluoro-Dglucose in tumor imaging with positron emission tomography. Mol. Imaging Biol. 4, 267-273 (2002).
8. Hara, T., Kosaka, N. and Kishi, H. PET imaging of prostate cancer using carbon-11-choline. J. Nucl. Med. 39, 990-995 (1998).
9. Kotzerke, J., Prang, J., Neumaier, B., Volkmer, B., Guhlmann, A., Kleinschmidt, K., Hautmann, R. and Reske, S. N. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur. J. Nucl. Med. 27, 1415-1419 (2000).
10. 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur. J. Nucl. Med. Mol. Imaging 32, 742-748 (2005).
11. DeGrado, T. R., Coleman, R. E., Wang, S., Baldwin, S. W., Orr, M. D., Robertson, C. N., Polascik, T. J. and Price, D. T. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 61, 110-117 (2001).
12. Coleman, R., DeGrado, T., Wang, S., Baldwin, S., Orr, M., Reiman, R. and Price, D. 9:30-9:45. Preliminary evaluation of F-18 Fluorocholine (FCH) as a PET tumor imaging agent. Clin. Positron Imaging 3, 147 (2000).
13. DeGrado, T. R., Baldwin, S. W., Wang, S., Orr, M. D., Liao, R. P., Friedman, H. S., Reiman, R., Price, D. T. and Coleman, R. E. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J. Nucl. Med. 42, 1805-1814 (2001).
14. Heinisch, M., Dirisamer, A., Loidl, W., Stoiber, F., Gruy, B., Haim, S. and Langsteger, W. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA(5 ng/ml? Mol. Imaging Biol. 8, 43-48 (2006).
15. 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer. Radiol. Med. 113, 895-904 (2008).
16. Schmid, D. T., John, H., Zweifel, R., Cservenyak, T., Westera, G., Goerres, G. W., von Schulthess, G. K. and Hany, T. F. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology 235, 623-628 (2005).
17. 18F-fluorocholine. J. Nucl. Med. 43, 92-96 (2002).
18. Bansal, A., Shuyan, W., Hara, T., Harris, R. A. and Degrado, T. R. Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L gliomabearing fisher rats. Eur. J. Nucl. Med. Mol. Imaging 35, 1192-1203 (2008).
19. Nadler, S., Hidalgo, J. and Bloch, T. Prediction of blood volume in normal human adults. Surgery 51, 224-232 (1962).